Carolina Batista Fernandes

Carolina Batista Fernandes

Auto-generated profile, based on publicly available information

Carolina Batista Fernandes

Instituto Nacional do Câncer

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Jornal Brasileiro de Doenças Sexualmente Transmissíveis
Verified
Journal Article
Open access
AGAndrea Menezes Gonçalves
Andrea Menezes Gonçalves
CFCarolina Batista Fernandes
Carolina Batista Fernandes
IMIlana Rangel Messias
Ilana Rangel Messias
SBStephanie Barcante
Stephanie Barcante
JMJulia Sampaio de Souza Morais
Julia Sampaio de Souza Morais
FFFernando Raphael de Almeida Ferry
Fernando Raphael de Almeida Ferry
Introduction: The elimination of congenital syphilis is a challenge in the field of public health worldwide. The failure of previous global plans forces authorities to rethink detection and control strategies, with compulsory notification being an important tool for obtaining data. Objective: To analyze the notifications of congenital syphilis made by Departamento de Vigilância Epidemiológica do Hospital Universitário Antônio Pedro (Department of Epidemiological Surveillance at Antônio Pedro University Hospital), between January 2016 and August 2020. Methods: Retrospective, descriptive, and quantitative study of data from congenital syphilis notification forms in Hospital Universitário Antônio Pedro from January 2016 to August 2020. In the descriptive analysis of categorical variables, absolute and relative frequencies were used; for numerical measures, central tendency and dispersion measures were used. Spearman correlation, Mann-Whitney test and Fisher’s exact test were performed in the R software (version 4.0.3). Hills’ criteria for causality were also considered. Results: Of the 67 forms examined, two were excluded due to duplication, and 48 variables were analyzed. No form was completely filled out, and some data were missing on more than 90% of them. According to maternal data, patients were mostly from Niterói (60%), had an average age of 23.09 years, and were brown (32.31%), while 13.85% did not finish 5th to 8th grade and 80% had prenatal care, but less than half had appropriate treatment indicated. As for the children: 55.38% were female, 40% brown, with an average age of 90.98 days. The great majority (72.31%) of them were born at Hospital Universitário Antônio Pedro, and not being born at this hospital was significant when it came to being asymptomatic (69.23%, p=0.001); the most frequent symptom was jaundice. Conclusion: Improvement in the follow-up and investigation of the reported cases can significantly decrease this high percentage of missing information, improving the quality of the data. The vast majority of patients underwent prenatal care, and therefore, they were avoidable cases, since the maternal diagnosis in the peripartum period occurs when the chance for vertical transmission has already occurred and caused consequences for the child’s life.

26 February 2025 in Mastology
Verified
Journal Article
Open access
CFCarolina Batista Fernandes
Carolina Batista Fernandes
RVRoberto Vieira
Roberto Vieira
MBMarcelo Barbosa
Marcelo Barbosa
EVEmanuelle Narciso Alvarez Valente
Emanuelle Narciso Alvarez Valente
MBMarcelo Adeodato Bello
Marcelo Adeodato Bello
MCMarcio Aurélio Pereira de Castro
Marcio Aurélio Pereira de Castro
In 2020, there were approximately 2.3 million new cases of breast cancer worldwide. Breast-conserving surgery followed by adjuvant radiotherapy has replaced radical and modified radical mastectomy as the standard treatment for patients with early-stage breast cancer, with equivalent overall survival and disease-free survival rates. Oncoplastic techniques consist in removing the tumor from the breast and applying plastic surgery techniques for breast reconstruction. The use of oncoplastic techniques may increase the number of women who experience postoperative complications or who are recalled for biopsy. Complication rates of around 16% can be considered acceptable, with the most common immediate complications being delayed wound healing, fat necrosis, and infection, while late complications being fibrosis and breast asymmetry. The use of hyperbaric oxygen therapy (HBOT) appears as an alternative for the treatment of these conditions. The Undersea and Hyperbaric Medical Society recognizes 14 valid medical indications for HBOT. Among these, those that stand out with interest in mastology are: chronic wounds; compromised flaps and grafts; radiotoxicity and soft tissue infections. Although most of the evidence is the result of observational studies or is extrapolated from the use of HBOT in other areas, its use may contribute to better outcomes in patients undergoing surgical treatment for breast cancer.